慢性阻塞性肺疾病急性加重期规范化管理的应用效果观察  

Observation of the Application Effect of Standardized Management in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

作　　者：陈玲[1] CHEN Ling(The Second Affiliated Hospital of Bengbu Medical College)

机构地区：[1]蚌埠医学院第二附属医院

出　　处：《中国标准化》2023年第22期293-296,共4页China Standardization

摘　　要：目的:研究慢性阻塞性肺疾病急性加重期规范化管理的应用效果。方法:选出蚌埠医学院第二附属医院2021年2月至2023年3月确诊的78例慢性阻塞性肺疾病患者,分组方式:抽签法,通过常规指导以及药物治疗的患者命名为参照组,通过规范化管理的患者命名为研究组,比较实施效果。结果:依从性结果比较,参照组数据占比(76.92%)明显比研究组数据占比(97.44%)低,2组存在较大差异,P<0.05。治疗前,2组患者的SGQR评分和急性发作次数对比差异不显著,P>0.05;治疗后,研究组患者的评分明显低于参照组,急性发作次数较参照组少,2组差异显著,P<0.05。结论:慢性阻塞性肺疾病急性加重期行规范化管理效果理想,可将患者用药依从性显著提升,临床治疗效果得到明显改善,临床应用价值极高,可广泛推行。Objective:To study the application effect of standardized management in acute exacerbation of chronic obstructive pulmonary disease.Methods:78 patients with chronic obstructive pulmonary disease diagnosed in the hospital from February 2021 to March 2023 were selected.Patients who received routine guidance and drug treatment were named as the reference group,and those who received standardized management were named as the research group,and the implementation effect was compared.Results:For the compliance results,the data proportion of the reference group(76.92%)was signifi cantly lower than that of the study group(97.44%),and there was a big difference between the two groups(P<0.05).There were no significant differences in SGQR scores and the number of acute attacks between the study group and the reference group before treatment(P>0.05).After early standardized treatment,routine guidance and treatment,the score of the study group was signifi cantly lower than that of the reference group,and the number of acute attacks of the study group was less than that of the reference group(P<0.05).Conclusion:The standardized management of acute exacerbation of chronic obstructive pulmonary disease has an ideal effect,which can not only signifi cantly improve the medication compliance of patients,but also signifi cantly improve the clinical therapeutic effect.The clinical application value is very high,and can be widely implemented.

关 键 词：慢性阻塞性肺疾病 急性加重期 规范化管理 不良事件 

分 类 号：R563.9[医药卫生—呼吸系统]